soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study soul trial oral semaglutide cardiovascular
Description
Kristina C
Demand is skyrocketing for FDA-approved medicines that provide incredible benefits to patients living with diabetes and obesity
In the eyes of some patients who feel especially empowered and health-bent, the medical home might be the family home
It's essential for people to be aware of these potential issues and to work with their healthcare providers to monitor and manage any side effects
